Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1976-4-2
pubmed:abstractText
From collected data on variable region sequences of heavy chains of immunoglobulins, the probability of random associations of any two amino-acid residues in the complementarity-determining segments was computed, and pairs of residues occurring significantly more frequently than expected were selected by computer. Significant associations between Phe 32 and Tyr 33, Phe 32 and Glu 35, and Tyr 33 and Glu 35 were found in six proteins, all of which were mouse myeloma proteins which bound phosphorylcholine (= phosphocholine). From the x-ray structure of McPC603, Tyr 33 and Glu 35 are contacting residues; a seventh phosphorylcholine-binding mouse myeloma protein also contained Phe 32 and Tyr 33 but position 35 had only been determined as Glx and thus this position had not been selected. Met 34 occurred in all seven phosphorylcholine-binding myeoma proteins but was also present at this position in 29 other proteins and thus was not selected; it is seen in the x-ray structure not to be a contacting residue. The role of Phe 32 is not obvious but it could have some conformational influence. A human phosphorylcholine-binding myeloma protien also had Phe, Tyr, and Met at positions 32, 33, and 34, but had Asp instead of Glu at position 35 and showed a lower binding constant. The ability to use sequence data to locate residues in complementarity-determing segments making contact with antigenic determinants and those playing essentially a structural role would contribute substantially to the understanding of antibody specificity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4129807, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4140089, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4213527, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4215080, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4435244, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4472818, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4522793, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4530984, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-46916, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4717746, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4773847, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-4851220, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-5290024, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-5508247, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-804915, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-806253, http://linkedlifedata.com/resource/pubmed/commentcorrection/1061162-813561
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
617-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1976
pubmed:articleTitle
Attempts to locate residues in complementarity-determining regions of antibody combining sites that make contact with antigen.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.